Synairgen Archives -

UK biotech Synairgen saw the value of its shares crater after its inhaled interferon beta therapy SNG001 was

Synairgen slumps as inhaled COVID drug fails pivotal test

https://pharmaphorum.com/news/synairgen-slumps-as-inhaled-covid-drug-fails-pivotal-test/

UK biotech Synairgen is pushing ahead with a phase 3 trial of SNG001 in hospitalised COVID-19 patients, after

Synairgen starts dosing inhaled COVID-19 drug in phase 3 trial

https://pharmaphorum.com/news/synairgen-starts-dosing-inhaled-covid-19-drug-in-phase-3-trial/

An inhaled drug developed by the UK firm Synairgen greatly reduces the chances of patients hospitalised with COVID-19 from progressing to more

Synairgen’s inhaled drug cuts chances of COVID-19 progressing

https://pharmaphorum.com/news/synairgens-inhaled-drug-cuts-chances-of-covid-19-progressing/

UK biotech Synairgen has started dosing patients in its phase 2 trial of SNG001, an inhaled formulation of

Synairgen doses first patients with COVID-19 drug

https://pharmaphorum.com/news/synairgen-doses-first-patients-with-covid-19-drug/

Two UK firms have announced plans to begin trials of therapies to tackle the coronavirus outbreak. Synairgen, based

Duo of UK firms announce coronavirus therapy trials

https://pharmaphorum.com/news/duo-of-uk-firms-announce-coronavirus-therapy-trials/

AZ assessing drug’s future following trial disappointment.

Synairgen under the weather after AZ halts asthma trial

https://pharmaphorum.com/news/synairgen-setback-az-halts-asthma-trial/

Synairgen